Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies

Chiranjeevi Gadiparthi, Amneet Hans, Kyle Potts, Mohammad K. Ismail

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

Although muscle weakness is the pathognomonic feature of idiopathic inflammatory myopathies, systemic organ involvement is not uncommon. The gastrointestinal and hepatic manifestations are well known. Oropharyngeal dysphagia is the most common gastrointestinal symptom and can be severe. Gastric and small intestinal motility disorders, including chronic intestinal pseudo-obstruction, celiac disease, and inflammatory bowel disease have been described. Comprehensive cancer screening is warranted soon after the diagnosis of inflammatory myopathies due to high risk of occult malignancies. Elevated aminotransferases may suggest muscular injury rather than hepatic dysfunction. Knowledge regarding systemic involvement of inflammatory myopathies can assist in timely diagnosis of these complex disorders.

Original languageEnglish
Pages (from-to)113-129
Number of pages17
JournalRheumatic Disease Clinics of North America
Volume44
Issue number1
DOIs
StatePublished - Feb 2018

Keywords

  • Corticosteroids
  • Creatine kinase
  • Dermatomyositis
  • Inclusion body myositis
  • Oropharyngeal dysphagia
  • Polymyositis

Fingerprint

Dive into the research topics of 'Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies'. Together they form a unique fingerprint.

Cite this